Diagnostics (Mar 2022)

The Use of Chest Magnetic Resonance Imaging in Malignant Pleural Mesothelioma Diagnosis

  • Federica Volpi,
  • Caterina A. D’Amore,
  • Leonardo Colligiani,
  • Alessio Milazzo,
  • Silvia Cavaliere,
  • Annalisa De Liperi,
  • Emanuele Neri,
  • Chiara Romei

DOI
https://doi.org/10.3390/diagnostics12030750
Journal volume & issue
Vol. 12, no. 3
p. 750

Abstract

Read online

In recent years, many articles have demonstrated that magnetic resonance imaging (MRI) may be performed successfully in the study of the chest. The aim of this study was to evaluate the potential role of MRI in the differentiation of benign from malignant pleural disease with a special focus on malignant pleural mesothelioma and on MRI protocols. A systematic literature search was performed to find original articles about chest MRI in patients with either benign or malignant pleural disease. We retrieved 1246 papers and 17 studies were finally identified as being in accordance with our purpose. For a morphologic assessment, T1-weighted and T2-weighted sequences were usually performed, eventually associated with T1 post-contrast sequences for better detection of pleural lesions. Functional sequences such as Diffusion Weighting Imaging (DWI), associated with the evaluation of Apparent Diffusion Coefficient (ADC) maps, were lately and gradually introduced in chest MRI protocols and their potentiality in differentiating benign from malignant disease has been investigated by many authors. Many progresses have been performed to improve quality images and diagnostic performances of MRI. A better and early identification of pleural disease may be obtained, providing MRI as a possible tool that can differentiate malignant from benign pleural disease without using invasive procedures.

Keywords